- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Indoco Remedies' board has approved its Q1 FY26 consolidated financial results. Revenue from operations hit ₹429.08 Cr, up 11.8% from last quarter. However, the company reported a consolidated net loss of ₹36.35 Cr. Auditors flagged ongoing losses and negative net worth at two subsidiaries (FPP Holding & Warren Remedies), noting "going concern" uncertainties. Management believes their investments are recoverable, seeing no immediate impairment. Despite the quarter's loss, management is confident of a future turnaround and sustained operational momentum.